The so-called successful cases in orthodox medicine

Independently from what they report, statistics never compare evidence with cases where there has been no therapy (no operation, radiation, chemotherapy, etc.) What I know, Abel (Heidelberg) is the first to dare mention this deficiency: "Zytostatic Chemotherapy of Advanced Epithelial Tumors". 

Faced with statements about discoveries of new methods against ‘cancer’, I always ask:

“Please tell me whether it helps in the conflict-active phase or in the vagotonic healing phase?”

Since the two phases are quite contrary, the new method cannot "help" both. 

It is obvious that one and the same medication cannot "help" in a phase that is fundamentally different from the other in all its possible physical parameters.

(I especially do not want to deepen the question: "To what extent does it make sense to therapeutically assist a meaningful healing mechanism in nature?"). 

The ontogenetic system of tumours logically shows that cytostatic drugs only stimulate old brain controlled tumours because they increase stress levels in the ca-phase. In the pcl-phase, on the other hand, cytostatic drugs retard healing, they block it and hinder the work of the necessary microbes. 

In any event, apparent symptomatic success in the pcl-phase of new brain (cerebrum) controlled cancers is possible by immediately blocking any healing process with cytostatic drugs. This is the case in mesodermal diseases such as bone cancer (in the pcl-phase leukaemia and bone sarcoma), or in testicular and ovarian necroses (interstitial) (in the pcl-phase testicular swelling and ovarian cysts, later indurated) or in lymph nodes necrosis (in the pcl-phase lymphoma). The swelling of any furuncle, abscess or even bee sting can be reduced with cytostatic drugs. Cytostatic drugs therefore only block the healing phases of mesodermal diseases and certainly achieve nothing more than illusory symptomatic successes.

A dissertation by Cl. Rohwedder, Dipl.-Psychologist and M.C. (1978) at the Medical University clinic in Hamburg is very interesting in reference to this situation: 445 patients with squamous epithelium cancer of the bronchi and adeno carcinoma of the alveoli were statistically studied (“Statistische Untersuchung über Bronchial Karzinom”). This very diligent work shows how difficult it is to compare these cases statistically.

Let us start with operability:
only 10% of the cases were operable. The surgeon obviously selected the best cases that he felt were operable which is why his results are marginally better than those of so-called radiation and chemo-therapists. Most deaths occurred after the first month. On average, all the patients died within three to four month. After 119 weeks, a little more than two years, the last patient died, and it was discovered that he had a pulmonary atelectasis, although he had had no complaints.
11% of the accidentally discovered lung carcinomas (in total 83) had adeno carcinoma. These would previously have been undiagnosed (as lung cancer) but instead would have been diagnosed as tuberculosis. Also interesting to note is that 30% of the diagnosed patients refused treatment. Whether or not any of those survived longer was not reported.

That would have been the most interesting question in view of the shattering therapy “successes” of othodox medicine, since the last patient died after 119 weeks.

Let us have a look at these figures from the perspective of Germanische Heilkunde®:

• Squamous epithelium Ca of the bronchi and pharyngeal arch duct cysts in the mediastinum
• Pulmonary (lung) nodules alveolar-adeno-carcinoma
• Tuberculosis
• Bronchial carcinoma was re-named lung cancer

Copyright by Dr. med. Ryke Geerd Hamer
Translated by El Glauner